ACUTA CAPITAL PARTNERS, LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 172 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$4,318,000
-8.4%
170,000
-33.7%
1.25%
-45.4%
Q1 2020$4,712,000
-44.8%
256,500
-33.8%
2.28%
+8.0%
Q4 2019$8,537,000
+41.0%
387,500
+0.8%
2.11%
-1.8%
Q2 2019$6,056,000
+25.7%
384,500
+16.9%
2.15%
-6.0%
Q1 2019$4,817,000328,8252.29%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,705,392$43,607,0007.88%
Bain Capital Life Sciences Investors, LLC 3,080,237$78,762,0004.46%
DAFNA Capital Management LLC 587,756$15,029,0003.57%
RTW INVESTMENTS, LP 7,463,291$190,836,0002.98%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$5,114,0002.79%
Evolutionary Tree Capital Management, LLC 122,473$3,132,0001.85%
Parkman Healthcare Partners LLC 303,268$7,755,0001.80%
Eagle Health Investments LP 161,125$4,120,0001.62%
BRIDGER MANAGEMENT, LLC 588,910$15,058,0001.41%
Woodline Partners LP 1,777,000$45,438,0001.01%
View complete list of DICERNA PHARMACEUTICALS INC shareholders